sb 203580 has been researched along with ristocetin in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (ristocetin) | Trials (ristocetin) | Recent Studies (post-2010) (ristocetin) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 1,515 | 23 | 125 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balduini, C; Canobbio, I; Reineri, S; Sinigaglia, F; Torti, M | 1 |
1 other study(ies) available for sb 203580 and ristocetin
| Article | Year |
|---|---|
A role for p38 MAP kinase in platelet activation by von Willebrand factor.
Topics: Antibodies, Monoclonal; Antigens, CD; Arachidonic Acid; Blood Platelets; Cyclooxygenase Inhibitors; Electrophoresis, Polyacrylamide Gel; Enzyme Activation; Enzyme Precursors; Humans; Imidazoles; Intracellular Signaling Peptides and Proteins; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Phospholipases A; Phospholipases A2; Phosphorylation; Platelet Activation; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Membrane Glycoproteins; Protein-Tyrosine Kinases; Pyridines; Receptors, IgG; Ristocetin; Signal Transduction; Syk Kinase; Thromboxane A2; Time Factors; von Willebrand Factor | 2004 |